Status:
COMPLETED
Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation
Lead Sponsor:
Germans Trias i Pujol Hospital
Conditions:
Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Purpose: To determine drusen morphology (volume and area) changes in nonexudative age-related macular degeneration (AMD) after one year of oral supplementation with AREDS-like formulation.
Detailed Description
Methods: Patients with AREDS category 2 and 3 AMD were prospectively enrolled in this study, and were randomized to receive daily oral supplementation with lutein (12mg) + zeaxanthin (2mg) + astaxanth...
Eligibility Criteria
Inclusion
- AREDS category 2 and 3 AMD
Exclusion
- AREDS category 4 AMD
- other ophthalmological diseases
- currently on antioxidant supplementation
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT02264938
Start Date
January 1 2013
End Date
October 1 2014
Last Update
October 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.